372 related articles for article (PubMed ID: 23302067)
1. Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.
Kohlmann A; Zech SG; Li F; Zhou T; Squillace RM; Commodore L; Greenfield MT; Lu X; Miller DP; Huang WS; Qi J; Thomas RM; Wang Y; Zhang S; Dodd R; Liu S; Xu R; Xu Y; Miret JJ; Rivera V; Clackson T; Shakespeare WC; Zhu X; Dalgarno DC
J Med Chem; 2013 Feb; 56(3):1023-40. PubMed ID: 23302067
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.
Ward RA; Brassington C; Breeze AL; Caputo A; Critchlow S; Davies G; Goodwin L; Hassall G; Greenwood R; Holdgate GA; Mrosek M; Norman RA; Pearson S; Tart J; Tucker JA; Vogtherr M; Whittaker D; Wingfield J; Winter J; Hudson K
J Med Chem; 2012 Apr; 55(7):3285-306. PubMed ID: 22417091
[TBL] [Abstract][Full Text] [Related]
3. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
[TBL] [Abstract][Full Text] [Related]
4. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
[TBL] [Abstract][Full Text] [Related]
6. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
[TBL] [Abstract][Full Text] [Related]
7. Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase.
Dragovich PS; Fauber BP; Corson LB; Ding CZ; Eigenbrot C; Ge H; Giannetti AM; Hunsaker T; Labadie S; Liu Y; Malek S; Pan B; Peterson D; Pitts K; Purkey HE; Sideris S; Ultsch M; VanderPorten E; Wei B; Xu Q; Yen I; Yue Q; Zhang H; Zhang X
Bioorg Med Chem Lett; 2013 Jun; 23(11):3186-94. PubMed ID: 23628333
[TBL] [Abstract][Full Text] [Related]
8. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
[TBL] [Abstract][Full Text] [Related]
9. Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use.
Kavanagh KL; Elling RA; Wilson DK
Biochemistry; 2004 Feb; 43(4):879-89. PubMed ID: 14744130
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy.
Fiume L; Manerba M; Vettraino M; Di Stefano G
Future Med Chem; 2014 Mar; 6(4):429-45. PubMed ID: 24635523
[TBL] [Abstract][Full Text] [Related]
11. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.
Rupiani S; Buonfiglio R; Manerba M; Di Ianni L; Vettraino M; Giacomini E; Masetti M; Falchi F; Di Stefano G; Roberti M; Recanatini M
Eur J Med Chem; 2015 Aug; 101():63-70. PubMed ID: 26114812
[TBL] [Abstract][Full Text] [Related]
12. Label-free high-throughput assays to screen and characterize novel lactate dehydrogenase inhibitors.
Vanderporten E; Frick L; Turincio R; Thana P; Lamarr W; Liu Y
Anal Biochem; 2013 Oct; 441(2):115-22. PubMed ID: 23871998
[TBL] [Abstract][Full Text] [Related]
13. Magnetic nanoparticles-based lactate dehydrogenase microreactor as a drug discovery tool for rapid screening inhibitors from natural products.
Cheng G; Pi Z; Zheng Z; Liu S; Liu Z; Song F
Talanta; 2020 Mar; 209():120554. PubMed ID: 31892010
[TBL] [Abstract][Full Text] [Related]
14. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
[TBL] [Abstract][Full Text] [Related]
15. Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening.
Buonfiglio R; Ferraro M; Falchi F; Cavalli A; Masetti M; Recanatini M
J Chem Inf Model; 2013 Nov; 53(11):2792-7. PubMed ID: 24138094
[TBL] [Abstract][Full Text] [Related]
16. Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.
Dragovich PS; Fauber BP; Boggs J; Chen J; Corson LB; Ding CZ; Eigenbrot C; Ge H; Giannetti AM; Hunsaker T; Labadie S; Li C; Liu Y; Liu Y; Ma S; Malek S; Peterson D; Pitts KE; Purkey HE; Robarge K; Salphati L; Sideris S; Ultsch M; VanderPorten E; Wang J; Wei B; Xu Q; Yen I; Yue Q; Zhang H; Zhang X; Zhou A
Bioorg Med Chem Lett; 2014 Aug; 24(16):3764-71. PubMed ID: 25037916
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).
Rai G; Brimacombe KR; Mott BT; Urban DJ; Hu X; Yang SM; Lee TD; Cheff DM; Kouznetsova J; Benavides GA; Pohida K; Kuenstner EJ; Luci DK; Lukacs CM; Davies DR; Dranow DM; Zhu H; Sulikowski G; Moore WJ; Stott GM; Flint AJ; Hall MD; Darley-Usmar VM; Neckers LM; Dang CV; Waterson AG; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2017 Nov; 60(22):9184-9204. PubMed ID: 29120638
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment.
Di Magno L; Coluccia A; Bufano M; Ripa S; La Regina G; Nalli M; Di Pastena F; Canettieri G; Silvestri R; Frati L
Eur J Med Chem; 2022 Oct; 240():114605. PubMed ID: 35868126
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.
Granchi C; Bertini S; Macchia M; Minutolo F
Curr Med Chem; 2010; 17(7):672-97. PubMed ID: 20088761
[TBL] [Abstract][Full Text] [Related]
20. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
